Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trialMwayiwawo Madanitsa, Feiko O. ter Kuile, Queen Saidi et al.|The Lancet|2023Cited by 72
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trialHellen C. Barsosio, Feiko O. ter Kuile, Mwayiwawo Madanitsa et al.|The Lancet|2024Cited by 21
Fetal growth and birth weight are independently reduced by malaria infection and curable sexually transmitted and reproductive tract infections in Kenya, Tanzania, and Malawi: A pregnancy cohort studyGeorge Mtove, Christentze Schmiegelow, R Matthew Chico et al.|International Journal of Infectious Diseases|2023Cited by 8